← back to search

Chad A. Hamilton

Case Western Reserve University · US
Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research focused on Gynecologic oncology and Endometrial cancer, with related work in Calcitriol receptor, Cancer research, Stage (stratigraphy). Notable publications include 'Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis', 'Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study', and 'Proteomics of the Human Endometrial Glandular Epithelium and Stroma from the Proliferative and Secretory Phases of the Menstrual Cycle1'.
h-index
citations
322
works
8
NIH funding
primary concept
email

Recent publications

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes
Gynecologic Oncology 2024cited by 8position: middledoi
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II
Gynecologic Oncology 2021cited by 28position: firstdoi
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
Scientific Reports 2021cited by 16position: middledoi
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study
Gynecologic Oncology 2018cited by 31position: middledoi
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study
American Journal of Obstetrics and Gynecology 2017cited by 60position: middledoi
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis
Gynecologic Oncology 2016cited by 100position: middledoi
Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention
Gynecologic Oncology 2016cited by 35position: middledoi
Proteomics of the Human Endometrial Glandular Epithelium and Stroma from the Proliferative and Secretory Phases of the Menstrual Cycle1
Biology of Reproduction 2015cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

G. Larry Maxwell · Roswell Park Comprehensive Cancer Center4 papers (2015–2024)Thomas P. Conrads · UPMC Hillman Cancer Center4 papers (2015–2024) · 3 papers (2015–2024)Kathleen M. Darcy · Palo Alto University3 papers (2016–2024)Floor Backes · Gynecologic Oncology Group2 papers (2017–2021)James Java · Roswell Park Comprehensive Cancer Center2 papers (2016–2017)Michael L. Pearl · Stony Brook School2 papers (2016–2017)David M. O’Malley · Bexley Hall2 papers (2016–2018) · 2 papers (2021–2024) · 2 papers (2015–2021)Joan L. Walker · Cornell University2 papers (2016–2017)Krishnansu S. Tewari · Chapman University2 papers (2016–2018)Brian L. Hood · UPMC Hillman Cancer Center2 papers (2015–2021)Robert S. Mannel · NRG Oncology2 papers (2016–2018)Yovanni Casablanca · Roswell Park Comprehensive Cancer Center2 papers (2021–2024)Oliver Zivanovic · Gynecologic Oncology Group2 papers (2016–2017)Nick M. Spirtos · University of Colorado Denver2 papers (2016–2017)J. Hunn · NorthShore University HealthSystem1 papers (2016–2016)Rusheeswar Challa · Michigan State University1 papers (2015–2015)Daniel S. Kapp · Palo Alto University1 papers (2024–2024)